Cargando…

In silico ADME predictions and in vitro antibacterial evaluation of 2-hydroxy benzothiazole-based 1,3,4-oxadiazole derivatives

In the present work, a library of fifteen 2-hydroxy benzothiazole-linked 1,3,4 -oxadiazole derivatives have been synthesized and confirmed using different analytical techniques. All of the synthesized compounds have been tested for antibacterial and in silico pharmacokinetic studies for the first ti...

Descripción completa

Detalles Bibliográficos
Autores principales: ALGHAMDI, Afnan Ahmed, ALAM, Mohammad Mahboob, NAZREEN, Syed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751938/
https://www.ncbi.nlm.nih.gov/pubmed/33488213
http://dx.doi.org/10.3906/kim-1912-55
_version_ 1783625756269608960
author ALGHAMDI, Afnan Ahmed
ALAM, Mohammad Mahboob
NAZREEN, Syed
author_facet ALGHAMDI, Afnan Ahmed
ALAM, Mohammad Mahboob
NAZREEN, Syed
author_sort ALGHAMDI, Afnan Ahmed
collection PubMed
description In the present work, a library of fifteen 2-hydroxy benzothiazole-linked 1,3,4 -oxadiazole derivatives have been synthesized and confirmed using different analytical techniques. All of the synthesized compounds have been tested for antibacterial and in silico pharmacokinetic studies for the first time. From the ADME predictions, compound 4 showed the highest in silico absorption percentage (86.77%), while most of the compounds showed more than 70% absorption. All of the compounds comply with the Lipinski rule of 5, suggesting that the compounds possess good drug likeness properties upon administration. Furthermore, all of the compounds follow the Veber rule, indicating good bioavailability and good intestinal absorption. The antibacterial results exhibited excellent to moderate activity. Compounds 5 , 9 , 12 , 14 , 15 , 16 , and 17 were the most active compounds against the tested bacterial strains. Compound 14 showed comparable MIC 6.25 ±0.2 μg/disc to the standard drug amoxicillin against the tested Gram-positive bacterial strains. Compounds 5 , 14 , 17 exhibited MIC 12.5 ±0.8 μg/disc, which was comparable to the standard drug against E. faecalis . It can be concluded that the synthesized compound could be used as a lead molecule in the development of new antibacterial agents with high efficacy.
format Online
Article
Text
id pubmed-7751938
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Scientific and Technological Research Council of Turkey
record_format MEDLINE/PubMed
spelling pubmed-77519382021-01-22 In silico ADME predictions and in vitro antibacterial evaluation of 2-hydroxy benzothiazole-based 1,3,4-oxadiazole derivatives ALGHAMDI, Afnan Ahmed ALAM, Mohammad Mahboob NAZREEN, Syed Turk J Chem Article In the present work, a library of fifteen 2-hydroxy benzothiazole-linked 1,3,4 -oxadiazole derivatives have been synthesized and confirmed using different analytical techniques. All of the synthesized compounds have been tested for antibacterial and in silico pharmacokinetic studies for the first time. From the ADME predictions, compound 4 showed the highest in silico absorption percentage (86.77%), while most of the compounds showed more than 70% absorption. All of the compounds comply with the Lipinski rule of 5, suggesting that the compounds possess good drug likeness properties upon administration. Furthermore, all of the compounds follow the Veber rule, indicating good bioavailability and good intestinal absorption. The antibacterial results exhibited excellent to moderate activity. Compounds 5 , 9 , 12 , 14 , 15 , 16 , and 17 were the most active compounds against the tested bacterial strains. Compound 14 showed comparable MIC 6.25 ±0.2 μg/disc to the standard drug amoxicillin against the tested Gram-positive bacterial strains. Compounds 5 , 14 , 17 exhibited MIC 12.5 ±0.8 μg/disc, which was comparable to the standard drug against E. faecalis . It can be concluded that the synthesized compound could be used as a lead molecule in the development of new antibacterial agents with high efficacy. The Scientific and Technological Research Council of Turkey 2020-08-18 /pmc/articles/PMC7751938/ /pubmed/33488213 http://dx.doi.org/10.3906/kim-1912-55 Text en Copyright © 2020 The Author(s) This article is distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0/ ), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Article
ALGHAMDI, Afnan Ahmed
ALAM, Mohammad Mahboob
NAZREEN, Syed
In silico ADME predictions and in vitro antibacterial evaluation of 2-hydroxy benzothiazole-based 1,3,4-oxadiazole derivatives
title In silico ADME predictions and in vitro antibacterial evaluation of 2-hydroxy benzothiazole-based 1,3,4-oxadiazole derivatives
title_full In silico ADME predictions and in vitro antibacterial evaluation of 2-hydroxy benzothiazole-based 1,3,4-oxadiazole derivatives
title_fullStr In silico ADME predictions and in vitro antibacterial evaluation of 2-hydroxy benzothiazole-based 1,3,4-oxadiazole derivatives
title_full_unstemmed In silico ADME predictions and in vitro antibacterial evaluation of 2-hydroxy benzothiazole-based 1,3,4-oxadiazole derivatives
title_short In silico ADME predictions and in vitro antibacterial evaluation of 2-hydroxy benzothiazole-based 1,3,4-oxadiazole derivatives
title_sort in silico adme predictions and in vitro antibacterial evaluation of 2-hydroxy benzothiazole-based 1,3,4-oxadiazole derivatives
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751938/
https://www.ncbi.nlm.nih.gov/pubmed/33488213
http://dx.doi.org/10.3906/kim-1912-55
work_keys_str_mv AT alghamdiafnanahmed insilicoadmepredictionsandinvitroantibacterialevaluationof2hydroxybenzothiazolebased134oxadiazolederivatives
AT alammohammadmahboob insilicoadmepredictionsandinvitroantibacterialevaluationof2hydroxybenzothiazolebased134oxadiazolederivatives
AT nazreensyed insilicoadmepredictionsandinvitroantibacterialevaluationof2hydroxybenzothiazolebased134oxadiazolederivatives